ArticleFood science & nutrition2025
Dietary Riboflavin Intake and the Risk of Stroke: Insights From NHANES 2007-2018.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Riboflavin Deficiency Is Highly Prevalent in Females and Children across High and Low/Middle Income Countries Worldwide.The Journal of nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There have been few studies examining the connection between dietary riboflavin intake and stroke. We aimed to investigate the prevalence of stroke and the association between dietary riboflavin intake and stroke in the United States population. Participants in this extensive, cross-sectional study were drawn from the National Health and Nutrition Examination Survey (NHANES) conducted between 2007 and 2018. Questionnaires and 24-h recall interviews were used to gather information on stroke events and dietary intake. To assess the relationships between riboflavin intake and stroke risk, multivariate logistic regression, restricted cubic spline, and subgroup analysis were used. The incidence of stroke was 3.67% among the 20,776 participants in the research. We discovered that a higher riboflavin consumption was linked to a decreased risk of stroke in people in the United States after controlling for all specified factors. For stroke risk, the odds ratio (OR; 95% confidence interval) for those with the highest riboflavin intake was 0.57 (95% CI: 0.38-0.85) compared to those with the lowest intake. Additionally, an L-shaped relationship between riboflavin intake and stroke risk was discovered by the study, with an inflection point at roughly 4.95 mg/day. According to our research, the risk of stroke was inversely correlated with a high riboflavin consumption. To validate our findings and investigate the causal links, more research is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.